Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI

Medical - Devices

Healthcare
$14.01 +7.25%

+$0.84 today

Market cap
$1.35B
Beta
2.18
P/E (TTM)
-34.3
EPS (TTM)
-$0.28
52W Low $6.45High $19.45

Volume 0.26M

Average 0.92M

LMRI Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Lumexa Imaging Holdings, Inc. Common StockNASDAQ: LMRI

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue of $227.68M in Q1 FY2026

Q1 FY2026 cost of revenue was $227.68M.

Context

  • Cost of revenue amounted to 88.5% of revenue in FY2025, down 1.3 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 2 fiscal years.
  • FY2025 was the highest annual figure in the 3 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$227.68M-4.3% QoQ
Last fiscal yearDec 2025
$905.9M+6.3% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+6.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
905.9M USD
Year-over-year change
+6.3%
2-year CAGR
+4.0%

Cost of Revenue vs competitors

How LMRI compares with its peers on the latest reported figures

  • LMRI's FY2025 cost of revenue of $905.9M is the lowest of the 2 companies compared; the peer median is $2.15B.
  • Its year-over-year change of +6.3% is the lowest of 2, against a peer median of +23.3%.
  • Cost of revenue amounts to 88.5% of revenue for LMRI, versus a peer median of 90.2%.
LMRI Competitors Peer median
Cost of Revenue for LMRI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RDNTRadNet, Inc.LTM Sep 2026$2.15B +23.3%+15.5%90.2%
LMRILumexa Imaging Holdings, Inc. Common StockFY2025$905.9M +6.3%—88.5%
Peer median (excluding LMRI) $2.15B+23.3%+15.5%90.2%

Competitors are the stored peer set for LMRI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue935.93M948.87M1.02B
Cost of Revenue836.96M852.61M905.9M
Gross Profit98.97M96.26M117.19M
Gross Margin10.6%10.1%11.5%
Research & Development000
Selling, General & Admin55.17M70.36M90.45M
Operating Expenses76.52M41.02M90.45M
Depreciation & Amortization72.14M57.16M55.39M
EBITDA94.58M114M141.71M
EBITDA Margin10.1%12.0%13.9%
Operating Income22.45M55.24M26.73M
Operating Margin2.4%5.8%2.6%
Interest Income000
Interest Expense141.69M136.03M118.54M
Other Income / Expenses(141.69M)(134.44M)(58.95M)
Income Before Tax(119.25M)(79.19M)(32.22M)
Pre-Tax Margin-12.7%-8.3%-3.1%
Income Tax Expense2.98M14.91M14.89M
Net Income(122.23M)(94.1M)(47.1M)
Net Margin-13.1%-9.9%-4.6%
EPS (Basic)(1.29)(1.00)(0.66)
EPS (Diluted)(1.29)(1.00)(0.66)
Weighted Avg Shares94.57M94.57M70.98M
Weighted Avg Shares (Diluted)94.57M94.57M70.98M

Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI

Intrinsic Alpha fair value

Locked

Current Price

$14.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.